If you invest in individual stocks, you’re probably used to seeing headlines about the top-performing stocks over shorter periods, such as for the year to date or even weekly or daily returns.

US stocks plunged on Monday as investors processed growing concerns about the health of the US economy after President Trump and his top economic officials acknowledged the possibility of a ...

With rapid growth and the stock trading for about 21 times forward earnings, now could be a great opportunity. PayPal fell sharply after its latest earnings report disappointed growth-seeking ...

Nvidia and Micron are excellent ways to invest in AI. Airbnb and Vertex Pharmaceuticals are two growth stocks that are worth a closer look. Enterprise Products Partners can be a passive-income ...

Last week, I highlighted 15 stocks that have created the most shareholder value over the 10-year period from 2015 through 2024, focusing on market appreciation in dollars. This time, I conducted a ...

The right online broker can help you execute your investment strategy and make trading cheap stocks seamless. Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap ...

If you're interested in exploring more stocks under $10 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Investing in stocks under $10 could ...

The stock finally dropped into free fall today, plunging more than 15 percent to mark one of the company’s worst trading days since it went public in 2010. The tumble erased the last vestiges of ...

The Nasdaq fell into a correction on Thursday. Data delayed at least 15 minutes Source: FactSet By The New York Times By Joe Rennison Stocks tumbled on Thursday, adding to a string of recent ...

Since CEO Elon Musk went to Washington, Tesla's stock has tumbled nearly 48%. Since Elon Musk went to Washington, D.C., to slash the government alongside President Donald Trump, the stock of his ...

Overview: Genenta Science S.p.A. is a clinical-stage biotechnology company based in Italy that focuses on developing hematopoietic stem cell gene therapies for treating solid tumors, with a market ...